StockData
AgomAb Therapeutics NV logo

AgomAb Therapeutics NV (AGMB) stock

AGMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 23, 2026Score 2/30
$5.92−0.05 (-0.84%)

Close on Nov 17, 2026Market cap $148.00KP/E –Yield –

AgomAb Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

AgomAb Therapeutics's price to book ratio was 0.0× on Nov 11, 2026.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.0×–

More AgomAb Therapeutics figures

See a number that looks wrong?